Original Article
Incidence and Determinants of COVID-19 Among People Who Smoke (2018–2021): Findings From the ITC EUREST-PLUS Spain Surveys
Dolors Carnicer-Ponta,b,c, Marcela Fua,b,c,d,
, Yolanda Castellanoa,b,c, Olena Tigovaa,b,c,e, Pete Driezenf,g, Anne C.K. Quahf, Susan C. Kaaif,g, Joan B. Sorianoc,h, Constantine I. Vardavasi,j,k, Geoffrey T. Fongf,g,l, Esteve Fernándeza,b,c,e
Corresponding author
a Tobacco Control Unit, Catalan Institute of Oncology – WHO Collaborating Centre for Tobacco Control, L’Hospitalet de Llobregat, Spain
b Tobacco Control Research Group, Bellvitge Biomedical Research Institute, L’Hospitalet de Llobregat, Spain
c Centre for Biomedical Research in Respiratory Diseases, Institute of Health Carlos III, Madrid, Spain
d Department of Public Health, Mental Health, and Maternal and Child Health Nursing, School of Nursing, University of Barcelona, Barcelona, Spain
e Department of Clinical Sciences, School of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain
f Department of Psychology, University of Waterloo, Waterloo, Canada
g School of Public Health Sciences, University of Waterloo, Waterloo, Canada
h Pneumology Department, Hospital Universitario de la Princesa, Madrid, Spain
i School of Medicine, University of Crete, Heraklion, Greece
j European Network for Smoking and Tobacco Prevention, Brussels, Belgium
k Department of Oral Health Policy and Epidemiology, Harvard School of Dental Medicine, Harvard University, Boston, MA, United States
l Ontario Institute for Cancer Research, Toronto, Canada
Ver más
